Igor Belyaev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Igor Belyaev has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
Eva Markova
Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
9 shared publications- Lucián Zastko
Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
8 shared publications Matus Durdik
Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
7 shared publicationsPavol Kosik
Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
7 shared publicationsLukas Jakl
Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
6 shared publicationsMilan Skorvaga
Department of Radiobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
5 shared publications
Latest Publications
- 19 October 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
Cytogenetic biodosimetry for radiotherapy: anthropomorphic phantom-based dose-response calibration and in vivo evaluation
Objectives: Cytogenetic biodosimetry has limited applicability in radiobiological monitoring of radiotherapy due to methodological constraints. To address this problem, we developed and evaluated an inverse biodosimetry approach that included cytogenetic dose-response curve (DRC) construction using an anthropomorphic tissue-equivalent phantom. Methods: Peripheral blood from a healthy donor was irradiated in vitro with 6 MV linac photons inside a RANDO phantom, reproducing dose distributions of a single radiotherapy fraction for glioblastoma or breast cancer with planned target volume doses 2.0 and 2.67 Gy, respectively. The resulting DRC for dicentric plus centric ring (Dic + CR) yield was fitted to the linear-quadratic model. Its applicability was explored using individual dose-volume data from 12 radiotherapy patients (5 glioblastoma, 7 breast cancer) to calculate expected Dic + CR yields, which were compared with aberration yields observed after the first treatment fraction. Results: The phantom-based DRC showed good agreement with the linear-quadratic model across the investigated dose range. Expected Dic + CR yields calculated from patient-specific dose-volume data were of the same order of magnitude as the observed yields but were lower in 10 of 12 patients. The association between expected and observed yields was positive but not statistically significant (r = 0.39, P = .21), Conclusions: The proof-of-concept for inverse cytogenetic biodosimetry using phantom-based DRC in radiotherapy patients was achieved. Further studies in larger patient cohorts are required to evaluate the influence of in vivo-specific biological factors. Advances in knowledge: This is the first study integrating an phantom-based cytogenetic DRC with patient-specific dose–volume data for chromosomal biodosimetry in radiotherapy context.
- 19 October 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
Cytogenetic biodosimetry for radiotherapy: anthropomorphic phantom-based dose-response calibration and in vivo evaluation
Objectives: Cytogenetic biodosimetry has limited applicability in radiobiological monitoring of radiotherapy due to methodological constraints. To address this problem, we developed and evaluated an inverse biodosimetry approach that included cytogenetic dose-response curve (DRC) construction using an anthropomorphic tissue-equivalent phantom. Methods: Peripheral blood from a healthy donor was irradiated in vitro with 6 MV linac photons inside a RANDO phantom, reproducing dose distributions of a single radiotherapy fraction for glioblastoma or breast cancer with planned target volume doses 2.0 and 2.67 Gy, respectively. The resulting DRC for dicentric plus centric ring (Dic + CR) yield was fitted to the linear-quadratic model. Its applicability was explored using individual dose-volume data from 12 radiotherapy patients (5 glioblastoma, 7 breast cancer) to calculate expected Dic + CR yields, which were compared with aberration yields observed after the first treatment fraction. Results: The phantom-based DRC showed good agreement with the linear-quadratic model across the investigated dose range. Expected Dic + CR yields calculated from patient-specific dose-volume data were of the same order of magnitude as the observed yields but were lower in 10 of 12 patients. The association between expected and observed yields was positive but not statistically significant (r = 0.39, P = .21), Conclusions: The proof-of-concept for inverse cytogenetic biodosimetry using phantom-based DRC in radiotherapy patients was achieved. Further studies in larger patient cohorts are required to evaluate the influence of in vivo-specific biological factors. Advances in knowledge: This is the first study integrating an phantom-based cytogenetic DRC with patient-specific dose–volume data for chromosomal biodosimetry in radiotherapy context.
- Open Access
- 17 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Stepwise sweeping-frequency ELF MF exposure and MTT-derived signal in U251 glioblastoma cells
- 17 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessStepwise sweeping-frequency ELF MF exposure and MTT-derived signal in U251 glioblastoma cells
- Open Access
- 6 June 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 322, 120336
Response to the BfS Statement: Scientific Clarifications on Chromosomal Damage and RF-EMF Exposure
- 6 June 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 322, 120336
Open AccessResponse to the BfS Statement: Scientific Clarifications on Chromosomal Damage and RF-EMF Exposure
- Open Access
- 24 April 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology
- Vol. 10 (2) , 316-323
Characterization of Static Magnetic Fields Produced by Smartphones
Smartphones integrate permanent magnets for speakers, cameras, vibration motors, or accessory magnetic snap systems, which generate static magnetic fields (SMF). While time-varying electromagnetic fields have been extensively studied, quantitative characterization of SMF remains limited. Modern smartphones generate measurable localized SMF hotspots that contribute to background electromagnetic exposure. In this study, we mapped the spatial distributions of SMF near smartphone surfaces and evaluated their potential biomedical relevance using computational exposure models. Three smartphone models released between 2021 – 2022 were measured with a triaxial magnetometer at multiple distances (5 – 50 mm) in triplicate, background-corrected, and analyzed for field intensity. Anatomical voxel models were used to simulate exposure conditions and field penetration into tissues. All smartphones exhibited heterogeneous SMF distributions with local hotspots, often exceeding 800 μT at close distances (<15 mm), associated mostly with speakers, microphones, magnetic rings, and camera modules. Although overall SMF levels were below the ICNIRP public whole-body exposure limit (400 mT), localized peaks approached thresholds relevant to interference with implantable cardiac devices (0.5 - 1 mT). Simulations confirmed localized field penetration into adjacent tissues under realistic smartphone use conditions. Modern smartphones generate spatially complex SMF exposures that, although compliant with public exposure limits, may approach levels reported to activate magnet mode in implantable cardiac devices and represent a minor yet pervasive component of electromagnetic exposure. These findings provide quantitative data for exposure characterization and electromagnetic compatibility assessment.
- 24 April 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Electromagnetics, RF and Microwaves in Medicine and Biology
- Vol. 10 (2) , 316-323
Open AccessCharacterization of Static Magnetic Fields Produced by Smartphones
Smartphones integrate permanent magnets for speakers, cameras, vibration motors, or accessory magnetic snap systems, which generate static magnetic fields (SMF). While time-varying electromagnetic fields have been extensively studied, quantitative characterization of SMF remains limited. Modern smartphones generate measurable localized SMF hotspots that contribute to background electromagnetic exposure. In this study, we mapped the spatial distributions of SMF near smartphone surfaces and evaluated their potential biomedical relevance using computational exposure models. Three smartphone models released between 2021 – 2022 were measured with a triaxial magnetometer at multiple distances (5 – 50 mm) in triplicate, background-corrected, and analyzed for field intensity. Anatomical voxel models were used to simulate exposure conditions and field penetration into tissues. All smartphones exhibited heterogeneous SMF distributions with local hotspots, often exceeding 800 μT at close distances (<15 mm), associated mostly with speakers, microphones, magnetic rings, and camera modules. Although overall SMF levels were below the ICNIRP public whole-body exposure limit (400 mT), localized peaks approached thresholds relevant to interference with implantable cardiac devices (0.5 - 1 mT). Simulations confirmed localized field penetration into adjacent tissues under realistic smartphone use conditions. Modern smartphones generate spatially complex SMF exposures that, although compliant with public exposure limits, may approach levels reported to activate magnet mode in implantable cardiac devices and represent a minor yet pervasive component of electromagnetic exposure. These findings provide quantitative data for exposure characterization and electromagnetic compatibility assessment.
- Open Access
- 19 January 2026
- Published by Elsevier in Environment International
- Vol. 208, 110075
On exposure–response interpretation and evidence synthesis in low-intensity RF-EMF research
- 19 January 2026
- Published by Elsevier in Environment International
- Vol. 208, 110075
Open AccessOn exposure–response interpretation and evidence synthesis in low-intensity RF-EMF research
- 7 August 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-10
Exposure of human lymphocytes to sweeping-frequency ELF MF
Whereas most of the research on possible bioeffects of extremely low frequency magnetic fields (ELF MF) on blood cells has been performed at 50/60 Hz regardless of background fields, here, we exposed human lymphocytes to sweeping-frequency ELF MF in a different range, defined by the DC background field of our incubator and the corresponding ion-cyclotron frequencies. Umbilical cord blood lymphocytes (UCBL) were isolated and exposed for 48 h to an ELF MF (sinusoidal, frequency sweeping 3-26 Hz) with 6 different amplitudes between 6 µT and 24 µT, utilizing an oblong coil. DNA double-strand breaks (DSB) were assessed by enumeration of γH2AX, 53BP1 and γH2AX/53BP1 co-localized DNA repair foci. Percentage of viable, early apoptotic (EA), and late apoptotic/necrotic (LAN) cells were determined. No statistically significant effects were seen for DNA repair foci or apoptosis induction after a 48-h exposure of UCBL with frequency-sweeping ELF MF. More than 2-fold decrease (p = .064) of γH2AX foci level was detected for 8 µT amplitude when compared to controls. For the same field intensity, a decrease in viable cells was suggested by the data. Our findings suggest that at least part of the exposure could have had a preventive/blocking effect on DNA DSB formation suggesting the possibility of using sweeping-frequency ELF MF as a protective measure against genotoxic agents. It is desirable to continue testing variations of the exposure utilized in this work, in order to search for the most biologically effective frequencies/patterns of exposure.
- 7 August 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- p. 1-10
Exposure of human lymphocytes to sweeping-frequency ELF MF
Whereas most of the research on possible bioeffects of extremely low frequency magnetic fields (ELF MF) on blood cells has been performed at 50/60 Hz regardless of background fields, here, we exposed human lymphocytes to sweeping-frequency ELF MF in a different range, defined by the DC background field of our incubator and the corresponding ion-cyclotron frequencies. Umbilical cord blood lymphocytes (UCBL) were isolated and exposed for 48 h to an ELF MF (sinusoidal, frequency sweeping 3-26 Hz) with 6 different amplitudes between 6 µT and 24 µT, utilizing an oblong coil. DNA double-strand breaks (DSB) were assessed by enumeration of γH2AX, 53BP1 and γH2AX/53BP1 co-localized DNA repair foci. Percentage of viable, early apoptotic (EA), and late apoptotic/necrotic (LAN) cells were determined. No statistically significant effects were seen for DNA repair foci or apoptosis induction after a 48-h exposure of UCBL with frequency-sweeping ELF MF. More than 2-fold decrease (p = .064) of γH2AX foci level was detected for 8 µT amplitude when compared to controls. For the same field intensity, a decrease in viable cells was suggested by the data. Our findings suggest that at least part of the exposure could have had a preventive/blocking effect on DNA DSB formation suggesting the possibility of using sweeping-frequency ELF MF as a protective measure against genotoxic agents. It is desirable to continue testing variations of the exposure utilized in this work, in order to search for the most biologically effective frequencies/patterns of exposure.
- 3 July 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (7) , 782-795
Construction and validation of joint dose-response curves for chromosome aberrations and interphase lymphocyte survival for cytogenetic biodosimetry of partial exposure
Cytogenetic biodosimetry of the Partial Body Irradiation (PBI) requires a dose response curve (DRC) for chromosome aberrations (ChA) but also an exponential coefficient D0 of the interphase cell survival (ICS) of irradiated lymphocytes. The aim of the present work was to construct joint DRCs in vitro for ChA and ICS and validate them in a setting with a limited number of blood donors. Blood samples from three healthy volunteers were irradiated in vitro with 6 MV Linac photons to a range of acute doses up to 5.46 Gy. Cytogenetic preparations were stained with Fluorescence-plus-Giemsa; ChA were scored in the first division metaphases. The ICS was assessed in PBI simulations, mixing irradiated and unirradiated blood 1:1 at each dose point; D0 was estimated by regression analysis. The DRC for dicentrics had linear and quadratic coefficients, respectively, 0.031 × cell-1 × Gy-1 and 0.070 × cell-1 × Gy-2; for dicentrics plus centric rings - respectively, 0.033 × cell-1 × Gy-1 and 0.083 × cell-1 × Gy-2. The ICS parameter D0 varied within 3.18 - 3.54 Gy, depending on the end-point used for the assessment. DRCs were successfully validated in a biodosimetry exercise with uniform irradiation and PBI simulations in vitro and using in vivo data from four breast cancer patients after their first radiotherapy dose fraction. Generating joint DRCs for ChA and ICS in a single experiment can be recommended as a rational methodology for laboratories practicing cytogenetic biodosimetry.
- 3 July 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (7) , 782-795
Construction and validation of joint dose-response curves for chromosome aberrations and interphase lymphocyte survival for cytogenetic biodosimetry of partial exposure
Cytogenetic biodosimetry of the Partial Body Irradiation (PBI) requires a dose response curve (DRC) for chromosome aberrations (ChA) but also an exponential coefficient D0 of the interphase cell survival (ICS) of irradiated lymphocytes. The aim of the present work was to construct joint DRCs in vitro for ChA and ICS and validate them in a setting with a limited number of blood donors. Blood samples from three healthy volunteers were irradiated in vitro with 6 MV Linac photons to a range of acute doses up to 5.46 Gy. Cytogenetic preparations were stained with Fluorescence-plus-Giemsa; ChA were scored in the first division metaphases. The ICS was assessed in PBI simulations, mixing irradiated and unirradiated blood 1:1 at each dose point; D0 was estimated by regression analysis. The DRC for dicentrics had linear and quadratic coefficients, respectively, 0.031 × cell-1 × Gy-1 and 0.070 × cell-1 × Gy-2; for dicentrics plus centric rings - respectively, 0.033 × cell-1 × Gy-1 and 0.083 × cell-1 × Gy-2. The ICS parameter D0 varied within 3.18 - 3.54 Gy, depending on the end-point used for the assessment. DRCs were successfully validated in a biodosimetry exercise with uniform irradiation and PBI simulations in vitro and using in vivo data from four breast cancer patients after their first radiotherapy dose fraction. Generating joint DRCs for ChA and ICS in a single experiment can be recommended as a rational methodology for laboratories practicing cytogenetic biodosimetry.
- Open Access
- 15 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Genetic instability in HSPC subpopulations of umbilical cord blood from patients with childhood acute lymphoblastic leukemia
Preleukemic stem cells (PSC) containing preleukemic fusion genes (PFG) arise prenatally and represent the initial stage of acute lymphoblastic leukemia (ALL) development. Despite widespread efforts, the cell of origin of PFG is still unclear. For the first time, in order to identify the immunophenotype of the PSCs, different subpopulations of hematopoietic stem and progenitor cells (HSPC) of umbilical cord blood (UCB) from ALL pediatric patients and control healthy children were sorted and analyzed for the presence of diagnostically-relevant PFGs by fluorescent in situ hybridization (FISH). Representative FISH results were confirmed by RT-qPCR and validated by sequencing of the products. Not only did we identify likely subpopulations of TEL/AML1+ PSC to be CD34+ CD38+ and CD34+ CD38− cells, but we also found markedly increased instability of often associated with ALL genes in UCB HSPC subpopulations of ALL pediatric patients. Our data show that CD34+ CD38+ as well as CD34+ CD38− cells are prone to genetic instability and most likely represent the target for malignant transformation in the development of ALL. Overall, together with confirming the prenatal origin of PFGs, this study provides further insight into the preleukemic stage of ALL and shows that ALL is a potentially screen able disease.
- 15 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessGenetic instability in HSPC subpopulations of umbilical cord blood from patients with childhood acute lymphoblastic leukemia
Preleukemic stem cells (PSC) containing preleukemic fusion genes (PFG) arise prenatally and represent the initial stage of acute lymphoblastic leukemia (ALL) development. Despite widespread efforts, the cell of origin of PFG is still unclear. For the first time, in order to identify the immunophenotype of the PSCs, different subpopulations of hematopoietic stem and progenitor cells (HSPC) of umbilical cord blood (UCB) from ALL pediatric patients and control healthy children were sorted and analyzed for the presence of diagnostically-relevant PFGs by fluorescent in situ hybridization (FISH). Representative FISH results were confirmed by RT-qPCR and validated by sequencing of the products. Not only did we identify likely subpopulations of TEL/AML1+ PSC to be CD34+ CD38+ and CD34+ CD38− cells, but we also found markedly increased instability of often associated with ALL genes in UCB HSPC subpopulations of ALL pediatric patients. Our data show that CD34+ CD38+ as well as CD34+ CD38− cells are prone to genetic instability and most likely represent the target for malignant transformation in the development of ALL. Overall, together with confirming the prenatal origin of PFGs, this study provides further insight into the preleukemic stage of ALL and shows that ALL is a potentially screen able disease.
- Open Access
- 30 May 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 279, 116486
Evaluation of oxidative stress and genetic instability among residents near mobile phone base stations in Germany
- 30 May 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 279, 116486
Open AccessEvaluation of oxidative stress and genetic instability among residents near mobile phone base stations in Germany